SMTL ID : 8a3q.1

Human Plasma Kallekrein in complex with 14W

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x UNL: UNKNOWN LIGAND

UNL.1: 20 residues within 4Å: Chain A: H.59, E.104, G.105, D.108, Y.180, K.181, I.182, M.186, A.198, C.199, K.200, S.203, T.221, S.222, W.223, G.224, G.226, G.234, V.235, Y.236 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:Y.180, A:I.182, A:W.223 Hydrogen bonds: A:G.105, A:K.200, A:S.203, A:S.222, A:G.224 pi-Stacking: A:H.59, A:W.223, A:W.223

1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)

MES.2: 7 residues within 4Å: Chain A: I.49, G.50, H.51, Q.52, W.53, L.129, T.250 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:H.51, A:Q.52, A:W.53 Water bridges: A:H.51, A:Y.120

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.3: 2 residues within 4Å: Chain A: N.21, I.159 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.21

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Davie, R.L. et al., Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema. J.Med.Chem. (2022)

Release Date

2022-11-02

Peptides

Plasma kallikrein: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Plasma kallikrein